Margherita Barbuti | Medicine | Best Researcher Award

Published on by Award and Honors

Dr. Margherita Barbuti | Medicine | Best Researcher Award

Medical doctor in private practice | University of Pisa | Italy

Dr. Margherita Barbuti is a highly regarded psychiatrist and clinical researcher recognized for her work in translational psychiatry, neurodevelopmental disorders, and psychopharmacology. Trained at the University of Pisa, she integrates clinical expertise with innovative research, focusing on mood disorders, addiction, and obesity-related psychiatric conditions. Her work bridges neuroscience and behavioral medicine, contributing to improved diagnostic and therapeutic approaches in mental health care. She has authored 55 scientific documents, which have collectively received 820 citations from 689 sources, reflecting her strong impact in the field. Additionally, she has served as an editor and reviewer for leading international journals and has participated in major clinical trials addressing complex psychiatric disorders. Through her research, teaching, and clinical leadership, Dr. Barbuti continues to advance evidence-based psychiatry and promote interdisciplinary collaboration, shaping the future of mental health research and practice.

Profiles : Scopus | ORCID 

Featured Publications 

Barbuti, M., et al. (2019). Personalized and precision medicine as informants for treatment management of bipolar disorder. International Clinical Psychopharmacology, 34(5), 237–245. — Cited by 138 articles.

Barbuti, M., et al. (2022). Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in bipolar patients. Journal of Affective Disorders, 297, 312–320. — Cited by 84 articles.

Barbuti, M., et al. (2021). Psychiatric comorbidities and emotional dysregulation in bariatric patients: Implications for surgical outcomes. Frontiers in Psychiatry, 12, 645872. — Cited by 67 articles.

Everett Magann | Health Professions | Best Research Article Award

Published on by Award and Honors

Prof. Everett Magann | Health Professions | Best Research Article Award

Research coordinator for MFM Fellowship | University of Arkansas for the Medical Sciences | United States

Dr. Everett F. Magann is a distinguished physician, educator, and researcher in Obstetrics, Gynecology, and Maternal-Fetal Medicine whose career spans both military and academic medicine, shaping the field of women’s health through clinical excellence, education, and groundbreaking research. He began his academic journey with a Bachelor of Science in Biology from Carson Newman College before earning his medical degree from the Medical College of Virginia, followed by residency training in Obstetrics and Gynecology and dual fellowships in Maternal-Fetal Medicine at the University of Mississippi Medical Center. His professional path reflects a rare blend of service and scholarship, having risen to the rank of Captain in the U.S. Naval Reserve while leading departments at major naval medical centers and later advancing academic medicine as a professor at the University of Arkansas for Medical Sciences. A prolific researcher with more than 467 peer-reviewed publications, 11,914 citations by 8,581 documents, and an h-index of 57, his work on amniotic fluid dynamics, high-risk pregnancy management, and ultrasound applications has influenced clinical guidelines and improved maternal and neonatal outcomes worldwide. His leadership has extended to innovations in surgical techniques, cesarean delivery outcomes, and telemedicine applications, ensuring equitable access to maternal care. Recognized with numerous honors for teaching, research, and clinical impact, including prestigious awards from national and international bodies, he continues to inspire future generations of physicians and researchers while shaping global standards in maternal-fetal medicine.

Profile : Scopus 

Featured Publication 

Magann, E. F. (n.d.). Amniotic fluid index as an admission test may increase the incidence of cesarean section in a community hospital. American College of Obstetricians and Gynecologists Meeting.

Shebli Atrash | Health Professions | Best Researcher Award

Published on by Award and Honors

Dr. Shebli Atrash | Health Professions | Best Researcher Award 

Dr. Shebli Atrash | Levine Cancer Institute | United States

Dr. Shebli Atrash, MD, MS, FACP, is a distinguished physician-scientist specializing in hematological malignancies and blood disorders. Currently serving as Associate Professor at Wake Forest University School of Medicine, he is deeply committed to advancing cancer research, patient care, and medical education. With an MD from the University of Damascus and advanced training in cancer biology at the University of Arkansas for Medical Sciences, Dr. Atrash has built a career centered on innovation in oncology. His expertise spans clinical practice, academic teaching, translational research, and leadership in clinical trials. Over the years, he has earned multiple recognitions for excellence, including Resident of the Year and awards for top accrual in clinical trials. As a reviewer and editor for leading journals and an active member of numerous professional societies, he continues to shape the global conversation in oncology. His dedication bridges scientific innovation with compassionate patient care.

Professional Profile: 

Scopus

ORCID

Google Scholar

Education

Dr. Atrash began his medical journey at the University of Damascus, where he earned his MD. His pursuit of deeper scientific knowledge led him to the University of Arkansas for Medical Sciences (UAMS), where he completed a Clinical Translational Science Certificate and a Master of Science in Interdisciplinary Biomedical Sciences with a cancer biology track. To complement his clinical and academic expertise, he also completed advanced leadership training through the Physician/APP Leadership Institute program at Atrium Health Levine Cancer Institute and Wake Forest University School of Medicine. His educational path reflects a balance of rigorous medical training, translational research expertise, and leadership development. Each step has prepared him to excel in bridging bedside care with cutting-edge oncology research. His lifelong learning commitment underscores his passion for improving outcomes for patients with hematologic malignancies.

Experience

Dr. Atrash’s professional journey demonstrates a remarkable blend of clinical excellence, academic leadership, and scientific research. He began his training as an Internal Medicine Intern and Resident at St. Barnabas Hospital/Albert Einstein College of Medicine, followed by a Hematology & Oncology Fellowship at UAMS. His faculty appointments span prestigious institutions, including the University of Arkansas for Medical Sciences, University of North Carolina, Atrium Health, and now Wake Forest University School of Medicine, where he serves as an Associate Professor in Hematology and Oncology. Beyond academia, Dr. Atrash has contributed to clinical trial development, serving on multiple advisory boards for leading pharmaceutical companies and acting as a reviewer and editor for top oncology journals. His wide-reaching experience also includes roles on independent review committees for pivotal Phase  clinical trials. With a career marked by leadership, innovation, and collaboration, Dr. Atrash is recognized as both a skilled clinician and a visionary researcher.

Research Interest

Dr. Atrash’s research interests center on hematological malignancies, with a special focus on multiple myeloma. He is deeply engaged in exploring novel therapies and clinical trials that advance patient care, including CAR-T cell therapy, antibody-drug conjugates, and combination regimens for relapsed/refractory myeloma. His translational work integrates cancer cell biology with therapeutic innovation, seeking to develop strategies that improve survival and quality of life for patients. He is currently the Principal Investigator of a multimillion-dollar investigator-initiated trial exploring Carfilzomib, Lenalidomide, Dexamethasone, and Belantamab Mafodotin for multiple myeloma. Additionally, his roles on the International Myeloma Working Group (IMWG), Southwest Oncology Group (SWOG), and CIBMTR reflect his influence on the global hematology research agenda. His interests also extend to improving clinical trial design, translational oncology, and immune-based therapies, positioning him as a leader in shaping the next generation of cancer therapeutics.

Awards

Dr. Atrash has consistently been recognized for his excellence in medicine, research, and clinical trials. Early in his career, he was honored as Resident of the Year at St. Barnabas Hospital. During his time at the University of Arkansas for Medical Sciences, he received the Dean’s Circle of Excellence Awards, highlighting his academic and clinical contributions. More recently, at Atrium Health, he was recognized as the Top Accruer for interventional and non-interventional clinical trials, showcasing his leadership in clinical research and dedication to advancing therapies for patients. These honors reflect his consistent ability to combine academic rigor, research innovation, and patient-centered care. Collectively, they illustrate a career built on excellence, impact, and recognition from both peers and leading institutions in oncology and internal medicine.

Publications

Dr. Atrash has authored and co-authored numerous impactful publications in top-tier oncology and hematology journals. His research spans multiple myeloma, novel therapeutics, and immune-based strategies, with publications widely cited by peers. He also serves as a reviewer, guest editor, and editorial board member for high-impact journals such as Cancers, British Journal of Haematology, and Annals of Blood. Selected publications include:

Title: Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
Citations: 2

Title: Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
Journal: Blood Cancer Journal, 2025

Title: A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
Journal: Blood, 2025

Title: Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
Journal: Clinical Lymphoma Myeloma and Leukemia, 2025

Title: Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
Journal: Blood Advances, 2025

Title: Global Access to Multiple Myeloma Therapies
Journal: JCO Global Oncology, 2025

Conclusion

Dr. Shebli Atrash is a highly qualified candidate for the Best Researcher Award, bringing together academic excellence, clinical innovation, and impactful service to the hematology and oncology community. His strong record in clinical trial leadership, journal editorships, and advisory roles establishes him as a distinguished researcher in multiple myeloma. With continued growth in authorship leadership, international visibility, and mentorship, Dr. Atrash’s career trajectory promises sustained contributions to cancer research and patient outcomes. Based on his strengths, he is highly suitable for this award.

Artee Gandhi | Health Professions | Best Researcher Award

Published on by Award and Honors

Dr  Artee Gandhi |  Health Professions |  Best Researcher Award

Physician at  University of Texas at Houston Medical School Doctor of Medicine ,  United States

Dr. Artee Gandhi is a distinguished pediatric anesthesiologist and pain management specialist with over two decades of experience in clinical care, research, and medical education. She currently serves as the Medical Director of Pediatric Pain Management at Cook Children’s Healthcare System in Fort Worth, Texas, and holds academic appointments as an Assistant Professor of Clinical Sciences at Texas Christian University School of Medicine and an Adjunct Clinical Assistant Professor at the University of North Texas Health Science Center.

Profile:

Education:

  • Doctor of Medicine (MD) – University of Texas at Houston Medical School (1995-1999)
  • B.A. in Psychology – University of Dallas (1991-1995)

Medical Training:

  • Pediatric Pain Management Fellowship – Stanford University, Lucile Packard Children’s Hospital
  • Pediatric Anesthesia Fellowship – Stanford University, Lucile Packard Children’s Hospital
  • Anesthesiology Residency – University of Missouri at Kansas City, St. Luke’s Hospital
  • Pediatrics Residency – University of Missouri at Kansas City, Children’s Mercy Hospital
  • Medical Acupuncture for Physicians – UCLA

Professional Experience:

  • Medical Director, Pediatric Pain Management & Pediatric Anesthesiologist – Cook Children’s Healthcare System (2009-Present)
  • Assistant Professor, Clinical Sciences – Texas Christian University School of Medicine (2022-Present)
  • Adjunct Clinical Assistant Professor, Pediatrics – University of North Texas Health Science Center (2017-Present)
  • Former Clinical Faculty – Stanford University, Lucile Packard Children’s Hospital

Certifications & Licensure:

  • Board Certified in Anesthesiology & Pediatrics
  • Licensed in Missouri, Texas, and California
  • PALS, BLS, and ACLS Provider

Honors & Awards:

  • Endowed Chair – Center for Pain Management and Integrative Therapies (2018-2022)
  • Cook Children’s Physician Network Service Award (2021)
  • Top Doctor – Fort Worth Magazine & 360 Magazine (Multiple Years)
  • Integrative Oncology Scholars Program – University of Michigan, funded by the National Cancer Institute
  • Research Mentor – University of North Texas Health Science Cente

Research & Leadership Roles:

  • Chairperson, Cook Children’s Hospital Wide Pain Committee & Opioid Stewardship Committee
  • Member, Fort Worth Safe Communities Drug Abuse & Overdose Prevention Task Force
  • Board Member, PRECISION Pain Registry & Trinity Valley School Campus Life Committee
  • Moderator, Chronic & Acute Pain Management Conferences

Professional Memberships:

  • American Society of Anesthesiology
  • American Academy of Pediatrics
  • Society of Pediatric Anesthesia & Pediatric Pain Medicine
  • International Association for the Study of Pain

Publication Top Notes:

Baastrup’s Disease in Pediatric Gymnasts
A.A. Ali, B.M. Jacobs, A. Gandhi, M.R. Brooks
Children, 2022 | Open Access | 2 Citations